Prognostic indicators of future disease activity in patients with relapsing multiple sclerosis (MS): an analysis from the AFFIRM study

被引：0
|
作者：
Kappos, L
O'Connor, PW
Havrdova, E
Hutchinson, M
Miller, DH
Phillips, JT
Polman, CH
Lublin, FD
Giovannoni, G
Wajgt, A
Lynn, F
Toal, M
Panzara, MA
Sandrock, AW
机构：
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[3] Gen Teaching Hosp, Prague, Czech Republic
[4] St Vincents Univ Hosp, Dublin, Ireland
[5] Inst Neurol, London WC1N 3BG, England
[6] Texas Neurol, Dallas, TX USA
[7] VU Med Ctr, Amsterdam, Netherlands
[8] Mt Sinai Sch Med, New York, NY USA
[9] Silesian Med Univ, Katowice, Poland
[10] Biogen Idec Inc, Cambridge, MA USA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2005年 / 238卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [1] Predictors of future disease activity in patients with relapsing multiple sclerosis
    Hutchinson, M
    O'Connor, PW
    Havrdova, E
    Kappos, L
    Miller, DH
    Phillips, JT
    Polman, CH
    Lublin, FD
    Giovannoni, G
    Wajgt, A
    Lynn, E
    Panzara, MA
    Sandrock, AW
    MULTIPLE SCLEROSIS, 2005, 11 : S152 - S152
  • [2] Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
    Havrdova, Eva
    Galetta, Steven
    Hutchinson, Michael
    Stefoski, Dusan
    Bates, David
    Polman, Chris H.
    O'Connor, Paul W.
    Giovannoni, Gavin
    Phillips, J. Theodore
    Lublin, Fred D.
    Pace, Amy
    Kim, Richard
    Hyde, Robert
    LANCET NEUROLOGY, 2009, 8 (03): : 254 - 260
  • [3] The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM
    Havrdova, E
    O'Connor, P
    Hutchinson, M
    Kappos, L
    Miller, D
    Phillips, JT
    Polman, C
    Lublin, F
    Giovannoni, G
    Wajgt, A
    Lynn, F
    Toal, M
    Panzara, M
    Sandrock, A
    JOURNAL OF NEUROLOGY, 2005, 252 : 46 - 46
  • [4] The efficacy of natalizumab on magnetic resonance imaging (MRI) measures in patients with relapsing multiple sclerosis (MS): Results from the AFFIRM trial
    Miller, D
    O'Connor, P
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Phillips, T
    Polman, C
    Lublin, F
    Giovannoni, G
    Wajgt, A
    Soon, D
    Fernando, K
    Lynn, F
    Toal, M
    Panzara, M
    Sandrock, A
    NEUROLOGY, 2005, 64 (06) : A147 - A147
  • [5] The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
    Hutchinson, Michael
    Kappos, Ludwig
    Calabresi, Peter A.
    Confavreux, Christian
    Giovannoni, Gavin
    Galetta, Steven L.
    Havrdova, Eva
    Lublin, Fred D.
    Miller, David H.
    O'Connor, Paul W.
    Phillips, J. Theodore
    Polman, Chris H.
    Radue, Ernst-Wilhelm
    Rudick, Richard A.
    Stuart, William H.
    Wajgt, Andrzej
    Weinstock-Guttman, Bianca
    Wynn, Daniel R.
    Lynn, Frances
    Panzara, Michael A.
    JOURNAL OF NEUROLOGY, 2009, 256 (03) : 405 - 415
  • [6] The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
    Michael Hutchinson
    Ludwig Kappos
    Peter A. Calabresi
    Christian Confavreux
    Gavin Giovannoni
    Steven L. Galetta
    Eva Havrdova
    Fred D. Lublin
    David H. Miller
    Paul W. O’Connor
    J. Theodore Phillips
    Chris H. Polman
    Ernst-Wilhelm Radue
    Richard A. Rudick
    William H. Stuart
    Andrzej Wajgt
    Bianca Weinstock-Guttman
    Daniel R. Wynn
    Frances Lynn
    Michael A. Panzara
    Journal of Neurology, 2009, 256 : 1035 - 1037
  • [7] The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
    M. Hutchinson
    L. Kappos
    P. A. Calabresi
    C. Confavreux
    G. Giovannoni
    S. L. Galetta
    E. Havrdova
    F. D. Lublin
    D. H. Miller
    P. W. O’Connor
    J. T. Phillips
    C. H. Polman
    E.-W. Radue
    R. A. Rudick
    W. H. Stuart
    A. Wajgt
    B. Weinstock-Guttman
    D. R. Wynn
    F. Lynn
    M. A. Panzara
    Journal of Neurology, 2009, 256 : 405 - 415
  • [8] The effect of natalizumab on brain atrophy in patients with relapsing multiple sclerosis: 2-year results from the AFFIRM study
    Fisher, E
    O'Connor, R
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, D
    Phillips, JT
    Polman, C
    Lublin, R
    Giovannoni, G
    Wajgt, A
    Rudick, R
    Lynn, F
    Toal, M
    Panzara, M
    Sandrock, A
    JOURNAL OF NEUROLOGY, 2005, 252 : 149 - 149
  • [9] Efficacy of Natalizumab Therapy in Patients of African Descent With Relapsing Multiple Sclerosis Analysis of AFFIRM and SENTINEL Data
    Cree, Bruce A. C.
    Stuart, William H.
    Tornatore, Carlo S.
    Jeffery, Douglas R.
    Pace, Amy L.
    Cha, Choon H.
    ARCHIVES OF NEUROLOGY, 2011, 68 (04) : 464 - 468
  • [10] The immunogenicity of natalizumab in patients with multiple sclerosis: Results from the AFFIRM study
    Giovannoni, G.
    O'Connor, P. W.
    Havrdova, E.
    Hutchinson, M.
    Kappos, L.
    Miller, D. H.
    Phillips, J. T.
    Polman, C. H.
    Lublin, F. D.
    Wajgt, A.
    Lynn, F.
    Panzara, M. A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (02): : 208 - 208
12345